FROM:
Scandinavian Journal of Gastroenterology 1996; 31 (220): 52–59
O'Keefe S.J.D.
Nutrition and intestinal function are intimately interrelated.
The chief purpose of the gut is to digest and absorb nutrients in
order to maintain life. Consequently, chronic gastrointestinal
(GI) disease commonly results in malnutrition and increased
morbidity and mortality. For example, studies have shown that
50-70% of adult patients with Crohn's disease were
weight-depleted and 75% of adolescents growth-retarded. On the
other hand, chronic malnutrition impairs digestive and absorptive
function because food and nutrients are not only the major
trophic factors to the gut but also provide the building blocks
for digestive enzymes and absorptive cells. For example, recent
studies of ours have shown that a weight loss of greater than 30%
accompanying a variety of diseases was associated with a
reduction in pancreatic enzyme secretion of over 80%, villus
atrophy and impaired carbohydrate and fat absorption. Finally,
specific nutrients can induce disease, for example,
gluten-sensitive enteropathy, whilst dietary factors such as
fibre, resistant starch, short-chain fatty acids, glutamine and
fish oils may prevent gastrointestinal diseases such as
diverticulitis, diversion colitis, ulcerative colitis, colonic
adenomatosis and colonic carcinoma. The role of dietary antigens
in the aetiology of Crohn's disease is controversial, but
controlled studies have suggested that elemental diets may be as
effective as corticosteroids in inducing a remission in patients
with acute Crohn's disease. In conclusion, nutrition has both a
supportive and therapeutic role in the management of chronic
gastrointestinal diseases. With the development of modern
techniques of nutritional support, the morbidity and mortality
associated with chronic GI disease can be reduced. On the other
hand, dietary manipulation may be used to treat or prevent
specific GI disorders such as coeliac disease, functional bowel
disease, Crohn's disease and colonic neoplasia. The future
development of nutria-pharmaceuticals is particularly attractive
in view of their low cost and wide safety margins.